[P2] Poster Session Core Time (偶数番号)

R&D IIVaccine Science

[P2-88] T-Cell Immunogenicity of AI-Predicted Malaria Vaccine Elements Assessed by IFN-γ Enzyme-Linked Immunospot Assay

*Shara Bakytbek^1,2,3, Agnieszka Gromadka⁴, Wataru Kagaya^3,5, Huai Chuang^3,6, Yarob Ibraheem^1,2,3, Farzaneh Valanezhad^1,2,3, Ayako Hyuga^1,2,3, Marius Gheorghe⁴, Daiki Miura⁷, Alexandru Odainic⁴, Shin-Ichi Inoue^2,8, Shusaku Mizukami^3,9, Satoshi Kaneko^3,5, Kazuhide Onoguchi⁷, Sebastian Kapell^4,10, Kaidre Bendjama⁴, Osamu Kaneko^3,6, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. NEC Oncoimmunity AS, Oslo (Norway), 5. Department of Eco-epidemiology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 6. Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 8. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 9. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 10. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan))

閲覧にはパスワードが必要です

ログイン

または